Clinical Trials · NCT03888157
A Research Study Looking at How Victoza® Works in People With Type 2 Diabetes in Iran, Followed in Local Clinical Routine
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 839
- Start date
- Mar 2019
- Locations
- 16 sites, Iran
- Primary endpoint
- Change in glycated haemoglobin A1c (HbA1c) (percentage)